Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06657976 · ClinicalTrials.gov registry record · Phase 2
Response to Exercise and Nitric Oxide in PAD
A Phase 2 study of Exercise and Peripheral Artery Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT06657976 is a Phase 2 study of Exercise and Peripheral Artery Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 200 participants, below the 8,907-participant average among 57 other Exercise trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06657976, a Phase 2 study of Exercise and Peripheral Artery Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether exercise "responders" have greater Δ nitrite increases compared to "non-responders"; 3) among non-responders, whether supplementing exercise with nitrate-rich beetroot juice between weeks 13-24 increases Δ nitrite and improves 6-minute walk at 24-week follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Supervised Treadmill Exercise
- COMBINATION_PRODUCT Nitrate-Rich Beetroot Juice + supervised exercise therapy
- COMBINATION_PRODUCT Placebo + supervised exercise therapy
Study Locations (2)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2029-10-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06657976
The ClinicalTrials.gov registry entry for NCT06657976 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,907-participant average among 57 other Exercise trials with a reported enrollment target (98% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Exercise appearing as the primary indexed condition, and to 4 interventions - of which Attention Control is the first listed.
NCT06657976 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06657976 about?
NCT06657976 is a clinical study titled "Response to Exercise and Nitric Oxide in PAD". RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether exercise "responders" have greater Δ nitrite increases compared to "non-responders"; 3) among non-resp...
What is the current status of trial NCT06657976?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-01-23. Estimated completion is 2029-10-01.
What conditions does trial NCT06657976 study?
This clinical trial studies the following conditions: Exercise, Peripheral Artery Disease, Intermittent Claudication, Nitric Oxide.
What interventions are being tested in trial NCT06657976?
The interventions under investigation include: Attention Control (BEHAVIORAL), Supervised Treadmill Exercise (BEHAVIORAL), Nitrate-Rich Beetroot Juice + supervised exercise therapy (COMBINATION_PRODUCT), Placebo + supervised exercise therapy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06657976?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06657976 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
-
Vasodilator and Exercise Study for DMD (VASO-REx)
RECRUITING · Phase 2
-
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
RECRUITING · Phase 2
-
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
COMPLETED · Phase 2
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.